Germany’s pharmacies under pressure: Statistical Yearbook 2025 now available
16.7.2025 11:22:20 CEST | news aktuell GmbH | Press Release
Berlin / Germany, 16 July 2025 – ABDA – Federal Union of German Associations of Pharmacists has released the Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025”. The publication offers a comprehensive overview of the latest trends in the pharmaceutical and healthcare sectors in Germany and beyond. It shows that the number of pharmacies has decreased again. At the end of 2024 there were 17.041 pharmacies in Germany, which is the lowest number since the end of the 1970s. One of the main reasons for the increasing number of pharmacy closures is the economic difficulties many pharmacies are facing. Since the pharmacy remuneration has not been elevated in the past 12 years, around 25 percent of German pharmacies have earnings below 75.000 Euros a year. Around 7 percent of German pharmacies made losses in 2024.
Those and other relevant facts and figures are shown on more than 130 pages in a revamped design of the new Statistical Yearbook – with several features that make the content easier to grasp than in previous years. In addition to statistics on Germany’s community pharmacies and their services, the range of international topics includes “Pharmacy Density across Europe”, “Supply Shortages in Europe”, “Ukrainians and Syrians in the Pharmacy Profession”, “Pharmacy-related Legal Regulations in Europe”, “Comparison by Country: Vaccinations in Pharmacies” and “Value-added Tax on Pharmaceuticals”. There is even a separate chapter on “Europe, Migration, Integration and Sustainability”.
ABDA’s Statistical Yearbook “German Pharmacies: Figures, Data, Facts 2025” was first published in German on the occasion of Pharmacy Day on 7 June 2025. Both German and English editions can be accessed and downloaded from ABDA’s website. ABDA is the top-level organisation for pharmacists in Germany. It represents the interests of the pharmaceutical healthcare professions in politics and society while promoting high-quality, comprehensive pharmaceutical care in Germany. ABDA is a member of the Pharmaceutical Group of the European Union (PGEU), the International Pharmaceutical Federation (FIP) and the World Pharmacy Council (WPC).
More Information at https://www.abda.de/en/
Contacts
Benjamin Rohrer, Spokesperson, +49-30-40004 131, b.rohrer@abda.de
Christian Splett, Deputy Spokesperson, +49-30-40004 137, c.splett@abda.de
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:28:00 CEST | Press Release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press Release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom